• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Acute versus chronic liver disease drives different cardiac injury programmes, review proposes

by
October 28, 2026
in Biology
Reading Time: 3 mins read
0
Acute versus chronic liver disease drives different cardiac injury programmes, review proposes

Acute versus chronic liver disease drives different cardiac injury programmes, review proposes

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The authors, Zheng Zhang, Yi Duan, Hongyu Huo and Zhifeng Gao, propose a conceptual framework that contrasts an “acute storm” with a “chronic siege” to organise what is known about liver-associated myocardial injury.

The review, published on 26 October 2026 as an open-access article, is explicitly a framework paper rather than a report of new experimental data. Its authors state that acute and chronic liver disease are associated with differing cardiac phenotypes and recovery trajectories, and they set out to compare the underlying signalling networks, immune-cell programming and injury mechanisms across these two settings, while allowing for overlap and transition between them.

In the acute scenario, the framework describes damage-associated molecular patterns and endotoxin as triggers of rapid, high-intensity activation of the TLR4/NF-κB signalling pathway, alongside mitochondrial oxidative stress. The review notes that ferroptosis and pyroptosis, two forms of regulated cell death, have been implicated as prominent programmes in preclinical models of acute cardiac injury. It is important to note that these are findings drawn from preclinical work, not from human clinical trials.

According to the proposed framework, the cardiac phenotype associated with this acute injury programme is predominantly functional depression, meaning the heart’s pumping performance is impaired, but with greater potential for recovery once the acute insult resolves. This contrasts with the chronic setting, where the authors argue the damage accumulates more slowly and is harder to reverse.

The chronic “siege” is described as sustained disruption of the gut-liver-heart axis, delivering persistent low-grade lipopolysaccharide, metabolic stressors and microbial metabolites to the cardiovascular system. The review suggests these sustained exposures may favour profibrotic macrophage states, contribute to impaired β-adrenergic reserve, and promote TGF-β-dependent fibroblast activation. The authors frame this as a self-reinforcing intercellular communication loop that culminates in progressive structural remodelling of the heart, with variable and often incomplete reversibility.

Between the two extremes, the review identifies a transitional grey zone. The authors present this boundary as a risk continuum rather than a fixed line separating acute from chronic injury.

The framework carries implications for future research priorities. The authors suggest that rapid control of acute inflammatory and injury pathways should be the focus for the storm scenario, while sustained metabolic and anti-fibrotic approaches would be more appropriate for the siege. They stress that these are suggested priorities for research rather than established therapeutic recommendations.

In other words, the central claims of the framework remain hypotheses to be verified, not confirmed clinical findings.

For readers following the field, the value of the paper lies less in new data than in its organising logic: it proposes that the timing and persistence of liver-derived inflammatory signals shape which signalling networks and cell death programmes dominate in the heart, and that this distinction should guide how researchers design the next generation of studies on liver-associated cardiac injury.

Subject of Research: How acute and chronic liver disease may injure the heart through distinct signalling and cell death pathways

Article Title: Acute storm versus chronic siege: divergent signalling networks and cell death programmes in liver-associated myocardial injury

Article References: Zhang, Z., Duan, Y., Huo, H., & Gao, Z. (2026). Acute storm versus chronic siege: divergent signalling networks and cell death programmes in liver-associated myocardial injury. Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03329-6

Image Credits: AI Generated

DOI: 10.1186/s12964-026-03329-6

Keywords: liver disease, myocardial injury, cardiac injury, inflammation, ferroptosis, pyroptosis, fibrosis, gut-liver-heart axis, TLR4, NF-kB, trained immunity, review

News Source: Drew Townsend. (October 28, 2026). Acute versus chronic liver disease drives different cardiac injury programmes, review proposes. Scienmag.

Tags: cardiac injuryferroptosisFibrosisgut-liver-heart axisinflammationliver diseasemyocardial injuryNF-kBpyroptosisReviewTLR4trained immunity
Share12Tweet7Share2ShareShareShare1

Related Posts

Deep learning tool reads 13 fungal morphotypes from plain microscope images

Deep learning tool reads 13 fungal morphotypes from plain microscope images

October 28, 2026
Unliganded Thyroid Hormone Receptor Steers Early Neural Development Without Its Hormone

Unliganded Thyroid Hormone Receptor Steers Early Neural Development Without Its Hormone

October 28, 2026

Parkin’s Metabolic Control Emerges as a Key Route to Tumor Suppression

October 28, 2026

Robin Sequence Airway Plates and AI Tools Take Center Stage at Brazilian Craniofacial Symposium

October 28, 2026

POPULAR NEWS

  • RNA methyltransferase NSUN2 stabilizes PARP9 transcript to drive breast cancer growth and immune escape, study finds

    RNA methyltransferase NSUN2 stabilizes PARP9 transcript to drive breast cancer growth and immune escape, study finds

    29 shares
    Share 12 Tweet 7
  • Linalool reshapes microbial networks during cigar tobacco fermentation, study finds

    29 shares
    Share 12 Tweet 7
  • Retrospective study wrongly claimed prospective validation, letter warns

    29 shares
    Share 12 Tweet 7
  • Sepsis Kills One in Three Patients in Mogadishu Emergency Department, Prospective Cohort Finds

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Biomarker model predicts severe amoebic liver abscess in Iraqi patients

Switzerland Builds a National Spinal Cord Injury Strategy From the Ground Up

Deep learning tool reads 13 fungal morphotypes from plain microscope images

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.